These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1686583)

  • 1. Gliclazide therapy of NIDDM in the 90s. Proceedings of 1st International Diamicron Symposium, September 24, 1990, Montreal, Canada.
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S1-92. PubMed ID: 1686583
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral treatment of diabetes mellitus: the contribution of gliclazide. Proceedings of a symposium, September 23, 1989, Lisbon, Portugal.
    Am J Med; 1991 Jun; 90(6A):1S-88S. PubMed ID: 1872300
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of NIDDM in the decade of the 90s.
    Krall LP
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S15-9. PubMed ID: 1794261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-insulin dependent diabetes. Role of gliclazide (diamicron)].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1995; ():313-22. PubMed ID: 7602890
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diamicron through the European Association for the Study of Diabetes and the International Diabetes Federation congresses in Sydney in 1988].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1989; ():315-9. PubMed ID: 2668621
    [No Abstract]   [Full Text] [Related]  

  • 6. International Symposium on Diabetes, Vascular Risks, and Gliclazide (Diamicron). Washington, DC, June 28, 1991.
    Metabolism; 1992 May; 41(5 Suppl 1):1-45. PubMed ID: 1349419
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study.
    Mailhot J
    Clin Ther; 1993; 15(6):1060-8. PubMed ID: 8111803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
    Palmer KJ; Brogden RN
    Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diamicron in the treatment of diabetes mellitus type 2].
    Balabolkin MI; Morozova TP; Chachiashvili MV
    Sov Med; 1987; (7):21-2. PubMed ID: 3317910
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of non-insulin-dependent diabetes mellitus (type II): management with gliclazide.
    Rifkin H
    Am J Med; 1991 Jun; 90(6A):3S-7S. PubMed ID: 1872302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliclazide in the treatment of obese NIDDM patients.
    Kumar S; Keswani P; Bose BS; Agrawal JK
    J Assoc Physicians India; 1994 Feb; 42(2):176-7. PubMed ID: 7646644
    [No Abstract]   [Full Text] [Related]  

  • 12. [A multicenter clinic study of slow-release-gliclazide in type 2 diabetes mellitus].
    Jia WP; Ning G; Gao X; Yan L; Yang HZ; Li M; Hong J; Lu ZQ; Cheng H; Qi YQ; Li ZW; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2636-9. PubMed ID: 16321325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights into metabolic and vascular management of type 2 diabetes. Proceedings of a meeting. Brussels, Belgium, September 1999.
    J Diabetes Complications; 2000; 14(4):179-233. PubMed ID: 11004424
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral treatment of diabetes mellitus: the contribution of gliclazide.
    Colwell JA
    Am J Med; 1991 Jun; 90(6A):1S-2S. PubMed ID: 1872299
    [No Abstract]   [Full Text] [Related]  

  • 16. [The efficacy and safety of 30 mg slow-released-gliclazide in type 2 diabetes mellitus].
    Li GW; Pan CY; Gao Y; Yuan SY; Yang WY; Xing XY; Tian H; Guo XH; Li HB
    Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):510-4. PubMed ID: 15312405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gliclazide on plasma lipids and pancreatic beta cell function in non-insulin-dependent diabetes mellitus.
    Chen KW; Juang JH; Huang HS; Lin JD; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1993 Dec; 16(4):246-50. PubMed ID: 8313208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliclazide, a better choice for type 2 diabetes.
    Tripathi BK
    J Assoc Physicians India; 1999 Oct; 47(10):1034. PubMed ID: 10778709
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medication of the month. Gliclazide modified release (Uni Diamicron)].
    Scheen AJ
    Rev Med Liege; 2003 Oct; 58(10):641-5. PubMed ID: 14677526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.